chr19-32991915-G-A
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_033103.5(RHPN2):c.1552C>T(p.Arg518Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0353 in 1,613,896 control chromosomes in the GnomAD database, including 1,858 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_033103.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RHPN2 | NM_033103.5 | c.1552C>T | p.Arg518Cys | missense_variant | 13/15 | ENST00000254260.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RHPN2 | ENST00000254260.8 | c.1552C>T | p.Arg518Cys | missense_variant | 13/15 | 1 | NM_033103.5 | P1 | |
RHPN2 | ENST00000544458.6 | n.1881C>T | non_coding_transcript_exon_variant | 10/12 | 2 | ||||
RHPN2 | ENST00000591502.1 | n.231C>T | non_coding_transcript_exon_variant | 1/2 | 2 | ||||
RHPN2 | ENST00000588388.5 | c.*1089C>T | 3_prime_UTR_variant, NMD_transcript_variant | 12/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0282 AC: 4295AN: 152158Hom.: 120 Cov.: 32
GnomAD3 exomes AF: 0.0453 AC: 11362AN: 251002Hom.: 511 AF XY: 0.0507 AC XY: 6877AN XY: 135680
GnomAD4 exome AF: 0.0360 AC: 52677AN: 1461620Hom.: 1737 Cov.: 31 AF XY: 0.0397 AC XY: 28897AN XY: 727112
GnomAD4 genome AF: 0.0282 AC: 4300AN: 152276Hom.: 121 Cov.: 32 AF XY: 0.0297 AC XY: 2210AN XY: 74454
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at